Please ensure Javascript is enabled for purposes of website accessibility

Why OncoMed Pharmaceuticals, AK Steel, and Intrawest Resorts Holdings Slumped Today

By Dan Caplinger - Apr 10, 2017 at 4:40PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite a solid market, these stocks fell. Find out why.

The stock market made modest gains on Monday, with major benchmarks finishing higher by small fractions of a percentage point on the day. Investors seemed pleased at the fact that the weekend was relatively quiet from a news standpoint, but optimism got reined in by uncertainty about whether hoped-for tax reform will get off the ground in Washington. Moreover, some negative news concerning individual companies weighed on sentiment to some extent, and some of the worst performers were OncoMed Pharmaceuticals (OMED), AK Steel (AKS), and Intrawest Resorts Holdings (SNOW). Below, we'll look more closely at these stocks to tell you why they did so poorly.

OncoMed takes a hit

Shares of OncoMed Pharmaceuticals plunged 37% after the company announced bad news on two fronts. First, the biopharma said that its phase 2 clinical trial of pancreatic cancer treatment demcizumab failed to meet its primary endpoint of progression-free survival of the disease. In addition, the trial failed to show benefits for taking demcizumab in combination with established treatments compared to simply taking those treatments without OncoMed's drug. OncoMed decided to discontinue the trial. In addition, OncoMed said that partner Bayer Pharmahad chosen not to exercise an option to license its vantictumab and ipafricept Wnt pathway inhibitor treatments. OncoMed tried to put a positive spin on the news, but the loss of Bayer as a potential partner points to a lack of confidence about the company's prospects going forward.

Chart detailing OncoMed's primary coverage areas.

Image source: OncoMed.

AK Steel hopes for better times ahead

AK Steel stock dropped 8% in the wake of a news report suggesting that the pricing strategy that the company and its domestic steelmaker peers implemented last year might not have been the best long-term strategy. The Wall Street Journal article (link may have paywall) pointed to the fact that several steelmakers raised prices after international rivals had to pay new import tariffs to get metal into the U.S. market. Although domestic steel companies like AK Steel were able to make dramatic increases that boosted short-term profit, the article suggests that customers were ill-prepared for the abrupt move and it put them in difficult situations. If demand for steel picks up, then the episode might not hurt AK Steel, but customers who found themselves in a bind will nevertheless want to be careful in working with the steel industry going forward.

Intrawest gets a lukewarm deal

Finally, shares of Intrawest Resorts Holdings fell 7%. The operator of ski resorts got a buyout bid from rival Aspen Skiing Company and a private equity partner, which agreed to spend $1.5 billion to buy the operator of the Winter Park and Steamboat ski areas in Colorado. Intrawest shareholders will receive $23.75 per share in cash, which represented a 40% premium above where the stock traded before takeover speculation surfaced back in January. Yet the agreed-upon price offers no premium to Friday's price, showing that investors have tended to get ahead of themselves hoping for big paydays from merger and acquisition activity.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

AK Steel Holding Corporation Stock Quote
AK Steel Holding Corporation
AKS
OncoMed Pharmaceuticals, Inc. Stock Quote
OncoMed Pharmaceuticals, Inc.
OMED
Intrawest Resorts Holdings, Inc. Stock Quote
Intrawest Resorts Holdings, Inc.
SNOW

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/22/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.